글로벌 전기진단기기 시장 – 2023-2030

Global Electro-Diagnostic Devices Market - 2023-2030

상품코드DMMD6130
발행기관DataM Intelligence
발행일2023.01.05
페이지 수200 Pages
포맷PDF + EXCEL
커버리지Global

₩6,525,000 – ₩11,775,000

보고서 요약(국문)

시장 개요
전 세계 전기진단기기 시장 규모는 2022년 YY백만 달러였으며, 2030년까지 YY백만 달러에 이를 것으로 예상되며, 예측 기간(2023-2030) 동안 연평균 성장률(CAGR)은 YY%입니다.
전기진단은 인체의 전기적 활동 속도 또는 정도를 측정하는 검사 기법입니다. 전기진단 장비는 근육과 신경의 전기 전도 또는 활동을 검사합니다. 이러한 장비는 의료진이나 의사가 근병증, 신경병증, 신경근 접합부 장애, 신경총병증과 같은 환자 진단을 내리는 데 도움을 줍니다. 주요 전기진단 검사에는 신경전도검사(NCS), 체성감각유발전위검사(SSEP), 근전도검사(EMG)가 포함됩니다.
시장 동향
신제품 출시 증가, 고령 인구 증가 및 이와 관련된 만성 질환의 증가는 예측 기간 동안 전 세계 전기진단기기 시장 성장을 촉진할 것으로 예상됩니다.

제품 출시 증가가 시장 성장을 촉진하고 있습니다.
시장 개발 증가, 고령 인구 증가 및 만성 질환 증가는 예측 기간 동안 전 세계 심전도 진단 기기 시장의 성장을 견인하고 있습니다. 예를 들어, 미국 FDA 승인을 받은 개인용 심전도(ECG) 기술 기업인 AliveCor는 2020년 9월, 임상적으로 검증된 개인용 ECG 기기인 KardiaMobile 6L을 인도 시장에 출시했습니다. KardiaMobile 6L은 세계에서 유일하게 6리드를 사용하는 FDA 승인 개인용 ECG 기기로, 가장 흔한 세 가지 부정맥인 심방세동(AFib), 서맥, 빈맥을 감지할 수 있습니다. 이러한 질환은 정기적인 모니터링이 필요하므로, 환자는 집에서 스스로 부정맥을 검사할 수 있습니다. KardiaMobile 6L은 단 30초 만에 의료 등급의 ECG를 기록할 수 있습니다. 또한, 2022년 10월 인도 최초의 비접촉식 원격 환자 모니터링(RPM) 회사인 Dozee는 심혈관 질환(CVD) 환자 모니터링을 위한 휴대용 심전도(ECG) 패치 출시를 발표했습니다.
더욱이, 2020년 7월에는 신경학, 인공지능(AI), 머신러닝 등 뇌 관련 제품 및 솔루션을 제공하는 의료기기 및 기술 회사인 Brain Scientific Inc.가 일회용 EEG 헤드셋인 NeuroCap에 새로운 기능을 추가하여 개선했습니다. 마찬가지로, 2022년 1월에는 Cadwell이 미국에서 음부신경(골반저) 자극 및 기록 전극과 케이블을 출시했습니다. Spes Medica에서 제작한 이 음부신경 전극은 Sierra Summit 시스템과 함께 개발되어 항문 괄약근의 음부신경 말단 운동 잠복기(PNTML)를 측정합니다. 따라서 위의 데이터는 제품 출시 증가가 예측 기간 동안 전 세계 전기 진단 기기 시장을 활성화시킬 것임을 보여줍니다.

높은 장비 가격은 전 세계 심전도 진단 기기 시장 성장을 저해할 것으로 예상됩니다.
시장 성장을 저해하는 주요 요인 중 하나는 심전도 진단 기기의 높은 설치 및 유지 관리 비용입니다. 예를 들어, 휴대용 심전도 기기는 500달러, 노트북 기반 심전도 기기는 1,000~2,000달러 정도입니다. 휴대용 심전도 기기는 평균 1,000~3,000달러입니다.
코로나19의 영향
코로나19 팬데믹은 전 세계 심전도 진단 기기 시장에 중간 정도의 영향을 미쳤습니다. 팬데믹 초기에는 코로나19에 대한 관심이 집중되면서 대부분의 진단 절차가 취소되거나 연기되었습니다. 이후 코로나19 확진자 수가 감소하면서 심전도 진단 절차가 철저한 예방 조치를 취하며 다시 시행되었습니다. 예를 들어, 2020년 초 미국에서는 비응급 외래 및 입원 환자 전기진단(EDx) 검사를 포함한 선택적 의료 시술이 취소되었습니다. 이후 일부 지역에서는 일일 신규 확진자 수가 감소했고, 미국 신경근육 및 전기진단 의학회(AANEM)의 지침에 따라 EDx 검사실이 재개되었습니다. 또한, COVID-19는 개인 맞춤형 모니터링 장치 개발을 촉진하여 시장에 긍정적인 영향을 미쳤습니다. 따라서, 앞서 언급한 자료들을 종합해 보면 COVID-19는 전 세계 전기진단 장치 시장에 복합적인 영향을 미쳤습니다.

세그먼트 분석
심전도(ECG) 장치는 예측 기간(2022-2029년) 동안 전기진단 장치 시장을 주도할 것으로 예상됩니다.

심전도(ECG) 제품은 예측 기간 동안 시장 점유율의 대부분을 차지할 것으로 추정됩니다. 전 세계적으로 심혈관 질환 발병 사례가 증가함에 따라 심전도(ECG) 장치 부문은 예측 기간 동안 높은 연평균 성장률(CAGR)을 기록할 것으로 예상됩니다. 예를 들어, 세계보건기구(WHO)에 따르면 심혈관 질환(CVD)은 전 세계적으로 주요 사망 원인이며 매년 1,790만 명 이상이 사망합니다. CVD 관련 사망자의 75% 이상이 저소득 및 중소득 국가에서 발생합니다. 세계심장연맹은 2030년까지 CVD 관련 사망자가 매년 2,300만 명을 넘어설 것으로 예측합니다.
또한, 심장 건강에 대한 인식을 확산하기 위한 다양한 기관의 노력이 증가함에 따라 예측 기간 동안 해당 부문의 성장이 촉진되고 있습니다. 예를 들어, 미국 국립심장폐혈연구소(NHLBI), The Heart Truth 및 미국 전역의 여러 단체는 매년 2월 첫째 주 금요일에 '전국 빨간 옷 입는 날(National Wear Red Day)'을 지정하여 미국인의 주요 사망 원인인 심장 질환에 대한 인식을 높이고 있습니다. 또한, 2019년 2월 10일, 심장재단은 호주 뉴스코프(News Corp Australia)와 협력하여 호주 국민에게 심장 질환이 국가의 주요 사망 원인임을 알리는 '연쇄 살인범(Serial Killer)' 광고 및 기사 캠페인을 시작했습니다. 이 캠페인은 호주 국민들에게 심장 질환 위험을 스스로 평가할 수 있는 사용하기 쉬운 온라인 도구인 심장 나이 계산기(Heart Age Calculator)를 제공했으며, 정부에 심장 건강 검진에 대한 메디케어 혜택을 제공하여 심장 질환 예방을 지원할 것을 촉구했습니다.
또한, CDC에서 운영하는 '밀리언 하츠(Million Hearts)'는 5년 동안 100만 건의 심장마비와 뇌졸중을 예방하기 위한 국가적 노력입니다. 이 캠페인은 모든 사람의 심혈관 건강을 향상시킬 수 있는 소수의 근거 기반 권장 사항과 목표를 시행하는 데 중점을 두고 있습니다. 따라서 이러한 데이터를 바탕으로 심전도(ECG) 장치 부문은 예측 기간 동안 높은 연평균 성장률(CAGR)을 기록할 것으로 예상됩니다.
지역 분석
북미는 전 세계 전기 진단 장치 시장에서 가장 큰 시장 점유율을 차지하고 있습니다.
북미는 선진 병원과 의료 인력의 증가, 그리고 이 지역의 의료비 지출 증가로 인해 예측 기간(2022-2029) 동안 전 세계 전기 진단 장치 시장의 대부분을 차지할 것으로 예상됩니다. 예를 들어, 미국 병원 협회에 따르면 현재 6,093개 이상의 병원이 920,531개 이상의 병상 수용 능력을 보유하고 있으며, 2022년에는 33,356,853명의 환자가 입원하여 1,213,881,001,000달러의 지출을 발생시켰습니다. 또한, 이 지역의 고령 인구 증가와 관련 만성 질환 사례 증가는 전 세계 전기 진단 기기 시장에서 이 지역의 지배력에 기여하고 있습니다. 예를 들어, 미국 인구 조사국에 따르면 2021년 미국에는 65세 이상 성인이 5,400만 명 이상 거주하고 있으며, 이는 미국 인구의 약 16.5%에 해당합니다. 미국의 고령 인구 수는 계속 증가하고 있으며, 2050년에는 65세 이상 성인 수가 8,570만 명에 달하여 미국 전체 인구의 약 20%를 차지할 것으로 예상됩니다.
또한, 미국 질병통제예방센터(CDC)에 따르면 미국 성인 10명 중 6명은 적어도 한 가지 이상의 만성 질환을 앓고 있습니다. 같은 자료에 따르면 2020년 미국에서 심장 질환으로 사망한 사람은 약 69만 7천 명입니다. 미국 심장 협회(AHA)는 2035년까지 미국 성인 1억 3천만 명 이상이 심장 질환을 앓게 될 것으로 추정했습니다. 따라서 이러한 데이터는 북미 지역이 예측 기간 동안 전 세계 전기 진단 기기 시장을 주도할 것임을 시사합니다.
경쟁 환경
전 세계 전기 진단 기기 시장은 소수의 주요 업체들이 시장 점유율의 대부분을 차지하는 비교적 집중된 시장 구조를 보입니다. 주요 시장 점유율을 보유한 업체로는 Stryker Corporation, Becton, Dickinson and Company, Boston Scientific, Medtronic, Abbot, Bionet America, Inc., Philips Healthcare, Cardinal Health, GE Healthcare, B. Braun Melsungen AG 등이 있습니다. 이들 주요 업체는 연구 개발, 제품 혁신, 그리고 전 세계 현지 공급업체 및 유통업체를 통한 제품 판매 확대에 집중하고 있습니다. 예를 들어, 2022년 11월 Bionet America, Inc.는 2025년까지 약 3억 유로의 비용 절감을 위해 진단 사업부 구조조정 계획을 발표했습니다.
GE Healthcare
개요:
GE Healthcare는 미국 일리노이주 시카고에 본사를 두고 있으며 2004년에 설립되었습니다. 미국 다국적 기업인 General Electric의 자회사입니다. 의료 영상 시술에 사용되는 영상 진단 장비 및 방사성 의약품의 주요 제조업체이자 유통업체입니다.
제품 포트폴리오:
GE Healthcare의 전기 진단 기기 제품 포트폴리오에는 CARESCAPE B450 모니터가 포함됩니다. CARESCAPE B450 모니터는 CARESCAPE ONE 모니터 또는 CARESCAPE 환자 데이터 모듈(PDM) 및 추가 e-모듈과 원활하게 연동되어 다양한 정보를 통해 환자를 모니터링할 수 있습니다. 휴대가 간편하고 가격이 저렴하며 응급실, 수술 센터 및 회복실을 염두에 두고 개발되었습니다.

글로벌 전기진단기기 시장 보고서는 약 40개 이상의 시장 데이터 표, 45개 이상의 그림, 그리고 약 200페이지 분량의 자료를 제공합니다.

보고서 요약(영어 원문)

Market Overview
The global electro-diagnostic devices market size was valued at US$ YY million in 2022 and is estimated to reach US$ YY million by 2030, growing at a CAGR of YY% during the forecast period (2023-2030).
Electro-diagnostics is a testing technique that estimates the body's speed or extent of electrical activity. Electro-diagnostics equipment examines muscle and nerve impulses' electrical conduction or activity. These devices help practitioners or physicians recommend diagnoses for patients such as myopathy, neuropathy, neuromuscular junction disorder, and plexopathy. The major electro-diagnostic study includes nerve conduction studies (NCS), somatosensory evoked potential studies (SSEPs), and electromyography (EMG).
Market Dynamics
The rising product introductions, growing geriatric population and associated chronic diseases are boosting the global electro-diagnostic devices market growth in the forecast period.
The increasing product launches are fueling growth in the market.
The increased market developments, growing geriatric population and chronic diseases are boosting the global Electro-Diagnostic Devices market growth in the forecast period. For instance, in September 2020, AliveCor, a US FDA-approved personal electrocardiogram (ECG) technology firm, today entered the Indian market with the introduction of its clinically-validated personal ECG device, KardiaMobile 6L, the world’s only six-lead, FDA-cleared personal ECG device and can detect three most common arrhythmias, the atrial fibrillation (AFib), bradycardia, and tachycardia. Since these conditions require regular monitoring, the patients can test themselves for these arrhythmias at home. The KardiaMobile 6L can record a medical-grade ECG in only 30 seconds. Also, in October 2022, Dozee, India’s first contactless remote patient monitoring (RPM) company, declared about launching an ambulatory electrocardiogram (ECG) patch to monitor cardiovascular disease (CVD) patients.
Moreover, in July 2020, Brain Scientific Inc., a medical device and technology company delivering products and solutions associated with the brain, including neurology, AI and machine learning, improved its disposable EEG headset, NeuroCap, with new features. Likewise, in January 2022, Cadwell launched the Pudendal (Pelvic Floor) Stimulating and Recording Electrode and Cable in the United States. The pudendal electrode, fabricated by Spes Medica, is developed with the Sierra Summit system to assess pudendal nerve terminal motor latency (PNTML) in the anal sphincter. Therefore, the data above indicates that the increased product introductions boost the global electro-diagnostic devices market during the forecasted period.
The high cost of the equipment is expected to hamper global electro-diagnostic devices market growth.
However, one of the important factors hampering the market growth is the high setup and upkeep costs of electro-diagnostic devices. For instance, handheld ECG machines can be $500, and laptop-based ECG machines cost about $1000-$2,000. At the same time, portable ECG machines cost between $1,000-$3,000 on average.
COVID-19 Impact.
The COVID-19 pandemic moderately impacted the global electro-diagnostic devices market. Most diagnostics procedures were canceled or postponed during the early pandemic day since the major focus was on COVID-19. Still, later with the decrease in cases of COVID-19, electro-diagnosis procedures were performed with extreme precautions. For instance, in early 2020, the cancellation of elective medical procedures in the United States, including non-urgent outpatient and inpatient electro-diagnostic (EDx) studies, was observed. While certain regions subsequently showed a decrease in daily new cases, EDx laboratories were reopened under the direction of the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM). Furthermore, COVID-19 led to the development of personalized monitoring devices which positively impacted the market. Therefore, from the data mentioned, COVID-19 had a mixed impact on the global electro-diagnostic devices market.
Segment Analysis
Electrocardiography (ECG) devices are expected to dominate the electro-diagnostic devices market throughout the forecast period (2022-2029).
Electrocardiography (ECG) product is estimated to hold most of the market share throughout the forecast period. The growing cases of cardiovascular diseases worldwide ensure that the electrocardiography (ECG) devices segment grows at a high CAGR during the forecast period. For instance, according to the WHO, cardiovascular diseases (CVDs) are the major cause of death globally, taking over 17.9 million lives annually. Over 75% of CVD-related deaths happen in low- and middle-income countries. The World Heart Federation forecasts over 23 million CVD-related deaths annually by 2030.
Furthermore, the increased initiatives by various entities to spread awareness about cardiac health are boosting segment growth in the forecasted period. For example, NHLBI, The Heart Truth, and organizations around the United States on National Wear Red Day marked each year on the first Friday in February to obtain greater awareness of heart disease as a leading cause of death for Americans. Also, on February 10, 2019, the Heart Foundation introduced the coordinated advertising and editorial ‘Serial Killer’ campaign in collaboration with News Corp Australia to point out to Australians that heart disease is the nation’s leading cause of death. The campaign delivered Australians with an easy-to-use online tool, the Heart Age Calculator, to enable them to evaluate their own risk for heart disease and called on the Government to support the prevention of heart disease by supplying a Medicare advantage for Heart Health Checks.
Additionally, CDC run Million Hearts is a national endeavor to avert 1 million heart attacks and strokes in the period of five years. It concentrates on enforcing a small set of evidence-based preferences and targets that can enhance cardiovascular health for all. Therefore, from the mentioned data, it is estimated that the electrocardiography (ECG) devices segment will grow at a high CAGR throughout the forecast period.
Geographical Analysis
North America holds the largest market share of global electro-diagnostic devices.
North America is anticipated to hold most of the global electro-diagnostic devices market during the forecasted period (2022-2029) because of the increasing number of developed and well-staffed hospitals and increased healthcare expenditure in this region. For instance, according to the American Hospital Association, currently, over 6,093 hospitals have more than 920,531 staff bed capacity, which in 2022 had over 33,356,853 admissions generating $ 1,213,881,001,000 of expenditure. In addition, the growing geriatric population and related chronic disease cases in this region contribute to the region's dominance over the global electro-diagnostic device market. For example, according to the United States Census Bureau, over 54 million adults ages 65 and older living in the United States in 2021, accounting for around 16.5% of the nation's population. The number of older U.S. adults is growing. By 2050, the total number of adults ages 65 and older is projected to reach 85.7 million, making up around 20% of the overall U.S. population.
Furthermore, according to the CDC, six out of ten U.S. adults have at least one chronic disease. Moreover, according to the same source, approximately 697,000 people in the United States died from heart disease in 2020. The American Heart Association estimated that By 2035 over 130 million U.S. adults will have some heart disease. Thus, the mentioned data indicates that North America will dominate the global electro-diagnostic devices market in the forecast period.
Competitive Landscape
The global electro-diagnostic devices market is fairly consolidated, with selected key players accounting for the predominant market share. The major players with significant market share include Stryker Corporation, Becton, Dickinson and Company, Boston Scientific, Medtronic, Abbot, Bionet America, Inc., Philips Healthcare, Cardinal Health, GE Healthcare, and B. Braun Melsungen AG, among others. The key players focus on R&D, product innovation, and product outreach through distribution through local suppliers and distributors worldwide. For instance, in November 2022, Bionet America, Inc. announced its plan to restructure its diagnostics division to make around 300 million euros in savings by 2025.
GE Healthcare
Overview:
GE Healthcare is headquartered in Chicago, Illinois, United States, and was founded in 2004. It is a subsidiary of the American Multinational Conglomerate General Electric. It is a leading manufacturer and distributor of diagnostic imaging and radiopharmaceuticals for imaging modalities used in medical imaging procedures.
Product Portfolio:
GE Healthcare’s product portfolio of electro-diagnostic devices has CARESCAPE B450 Monitor: The CARESCAPE B450 monitor functions seamlessly with the CARESCAPE ONE monitor or CARESCAPE Patient Data Module (PDM) and one additional e-module, delivering the ability to monitor patients with various insights. Portable and inexpensive, it's developed with emergency departments, surgery centers, and step-down units in mind.
The global electro-diagnostic devices market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Product Launches
4.1.1.2. Growing Prevalence of Chronic Diseases
4.1.2. Restraints
4.1.2.1. High Cost of devices
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturer's Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Electrocardiography (ECG)
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Electromyogram (EMG)
7.4. Electroencephalography (EEG)
7.5. Nerve Conduction (NCS)
7.6. Electroretinography (ERG)
7.7. Electrogastrography (EGG)
8. By Product Mobility
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Mobility
8.1.2. Market Attractiveness Index, By Product Mobility
8.2. Stationary
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Portable
9. By End User
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals and Clinics
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
9.3. Ambulatory Surgical Centers (ASCs)
9.4. Homecare
9.5. Diagnostic Centers
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Mobility
10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Mobility
10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. U.K.
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Mobility
10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Mobility
10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Mobility
10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11. Competitive Landscape
11.1. Key Developments and Strategies
11.2. Company Share Analysis
11.3. Product Benchmarking
12. Company Profiles
12.1. GE Healthcare
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Key Highlights
12.1.4. Financial Overview
12.2. Medtronic
12.3. Abbott
12.4. Boston Scientific
12.5. Bionet America, Inc.
12.6. Philips Healthcare
12.7. Cardinal Health
12.8. B. Braun Melsungen AG
12.9. Stryker Corporation
12.10. Becton, Dickinson and Company
LIST NOT EXHAUSTIVE
13. DataM
13.1. Appendix
13.2. About Us and Services
13.3. Contact Us

언급된 주요 기업들

GE Healthcare, Medtronic, Abbott, Boston Scientific, Bionet America, Inc., Philips Healthcare, Cardinal Health, B. Braun Melsungen AG, Stryker Corporation, Becton, Dickinson and Company

표 목록 (Tables)

List of Tables

Table No. 1 Global Electro-Diagnostic Devices Market Value, By Product Type,2022, 2026 & 2030 ($ Million)

Table No. 2 Global Electro-Diagnostic Devices Market Value, By Product Mobility,2022, 2026 & 2030 ($ Million)

Table No. 3 Global Electro-Diagnostic Devices Market Value, By End User,2022, 2026 & 2030 ($ Million)

Table No. 4 Global Electro-Diagnostic Devices Market Value, By Region,2022, 2026 & 2030 ($ Million)

Table No. 5 Global Electro-Diagnostic Devices Market Value, By Product Type,2022, 2026 & 2030 ($ Million)

Table No. 6 Global Electro-Diagnostic Devices Market Value, By Product Type, 2021-2030 ($ Million)

Table No. 7 Global Electro-Diagnostic Devices Market Value, By Product Mobility,2022, 2026 & 2030 ($ Million)

Table No. 8 Global Electro-Diagnostic Devices Market Value, By Product Mobility, 2021-2030 ($ Million)

Table No. 9 Global Electro-Diagnostic Devices Market Value, By End User,2022, 2026 & 2030 ($ Million)

Table No. 10 Global Electro-Diagnostic Devices Market Value, By End User, 2021-2030 ($ Million)

Table No. 11 Global Electro-Diagnostic Devices Market Value, By Region,2022, 2026 & 2030 ($ Million)

Table No. 12 Global Electro-Diagnostic Devices Market Value, By Region, 2021-2030 ($ Million)

Table No. 13 North America Electro-Diagnostic Devices Market Value, By Product Type, 2021-2030 ($ Million)

Table No. 14 North America Electro-Diagnostic Devices Market Value, By Product Mobility, 2021-2030 ($ Million)

Table No. 15 North America Electro-Diagnostic Devices Market Value, By End User, 2021-2030 ($ Million)

Table No. 16 North America Electro-Diagnostic Devices Market Value, By 0, 2021-2030 ($ Million)

Table No. 17 North America Electro-Diagnostic Devices Market Value, By Country, 2021-2030 ($ Million)

Table No. 18 South America Electro-Diagnostic Devices Market Value, By Product Type, 2021-2030 ($ Million)

Table No. 19 South America Electro-Diagnostic Devices Market Value, By Product Mobility, 2021-2030 ($ Million)

Table No. 20 South America Electro-Diagnostic Devices Market Value, By End User, 2021-2030 ($ Million)

Table No. 21 South America Electro-Diagnostic Devices Market Value, By Country, 2021-2030 ($ Million)

Table No. 22 Europe Electro-Diagnostic Devices Market Value, By Product Type, 2021-2030 ($ Million)

Table No. 23 Europe Electro-Diagnostic Devices Market Value, By Product Mobility, 2021-2030 ($ Million)

Table No. 24 #REF!

Table No. 25 Europe Electro-Diagnostic Devices Market Value, By End User, 2021-2030 ($ Million)

Table No. 26 Europe Electro-Diagnostic Devices Market Value, By 0, 2021-2030 ($ Million)

Table No. 27 Europe Electro-Diagnostic Devices Market Value, By Country, 2021-2030 ($ Million)

Table No. 28 Asia-Pacific Electro-Diagnostic Devices Market Value, By Product Type, 2021-2030 ($ Million)

Table No. 29 Asia-Pacific Electro-Diagnostic Devices Market Value, By Product Mobility, 2021-2030 ($ Million)

Table No. 30 Asia-Pacific Electro-Diagnostic Devices Market Value, By End User, 2021-2030 ($ Million)

Table No. 31 Asia-Pacific Electro-Diagnostic Devices Market Value, By Country, 2021-2030 ($ Million)

Table No. 32 Middle East & Africa Electro-Diagnostic Devices Market Value, By Product Type, 2021-2030 ($ Million)

Table No. 33 Middle East & Africa Electro-Diagnostic Devices Market Value, By Product Mobility, 2021-2030 ($ Million)

Table No. 34 Middle East & Africa Electro-Diagnostic Devices Market Value, By End User, 2021-2030 ($ Million)

Table No. 35 Medtronic: Overview

Table No. 36 Medtronic: Product Portfolio

Table No. 37 Medtronic: Key Developments

Table No. 38 Abbot: Overview

Table No. 39 Abbot: Product Portfolio

Table No. 40 Abbot: Key Developments

Table No. 41 Boston Scientific: Overview

Table No. 42 Boston Scientific: Product Portfolio

Table No. 43 Boston Scientific: Key Developments

Table No. 44 Bionet America, Inc.: Overview

Table No. 45 Bionet America, Inc.: Product Portfolio

Table No. 46 Bionet America, Inc.: Key Developments

Table No. 47 Philips Healthcare: Overview

Table No. 48 Philips Healthcare: Product Portfolio

Table No. 49 Philips Healthcare: Key Developments

Table No. 50 GE Healthcare: Overview

Table No. 51 GE Healthcare: Product Portfolio

Table No. 52 GE Healthcare: Key Developments

Table No. 53 Cardinal Health: Overview

Table No. 54 Cardinal Health: Product Portfolio

Table No. 55 Cardinal Health: Key Developments

Table No. 56 B. Braun Melsungen AG: Overview

Table No. 57 B. Braun Melsungen AG: Product Portfolio

Table No. 58 B. Braun Melsungen AG: Key Developments

Table No. 59 Stryker Corporation: Overview

Table No. 60 Stryker Corporation: Product Portfolio

Table No. 61 Stryker Corporation: Key Developments

Table No. 62 Becton, Dickinson and Company: Overview

Table No. 63 Becton, Dickinson and Company: Product Portfolio

Table No. 64 Becton, Dickinson and Company: Key Developments

그림 목록 (Figures)

List of Figures

Figure No. 1 Global Electro-Diagnostic Devices Market Share, By Product Type, 2022 & 2030 (%)

Figure No. 2 Global Electro-Diagnostic Devices Market Share, By Product Mobility, 2022 & 2030 (%)

Figure No. 3 Global Electro-Diagnostic Devices Market Share, By End User, 2022 & 2030 (%)

Figure No. 4 Global Electro-Diagnostic Devices Market Share, By Region, 2022 & 2030 (%)

Figure No. 5 Global Electro-Diagnostic Devices Market Value, 2021-2030 ($ Million)

Figure No. 6 Global Electro-Diagnostic Devices Market Y-o-Y Growth, By Product Type, 2022-2030 (%)

Figure No. 7 Electrocardiography (ECG): Global Electro-Diagnostic Devices Market Value, 2021-2030 ($ Million)

Figure No. 8 Electromyogram (EMG): Global Electro-Diagnostic Devices Market Value, 2021-2030 ($ Million)

Figure No. 9 Electroencephalography (EEG): Global Electro-Diagnostic Devices Market Value, 2021-2030 ($ Million)

Figure No. 10 Nerve Conduction (NCS): Global Electro-Diagnostic Devices Market Value, 2021-2030 ($ Million)

Figure No. 11 Electroretinography (ERG): Global Electro-Diagnostic Devices Market Value, 2021-2030 ($ Million)

Figure No. 12 Electrogastrography (EGG): Global Electro-Diagnostic Devices Market Value, 2021-2030 ($ Million)

Figure No. 13 Global Electro-Diagnostic Devices Market Y-o-Y Growth, By Product Mobility, 2022-2030 (%)

Figure No. 14 Stationary: Global Electro-Diagnostic Devices Market Value, 2021-2030 ($ Million)

Figure No. 15 Portable: Global Electro-Diagnostic Devices Market Value, 2021-2030 ($ Million)

Figure No. 16 Global Electro-Diagnostic Devices Market Y-o-Y Growth, By End User, 2022-2030 (%)

Figure No. 17 Hospitals & clinics: Global Electro-Diagnostic Devices Market Value, 2021-2030 ($ Million)

Figure No. 18 Ambulatory Centers: Global Electro-Diagnostic Devices Market Value, 2021-2030 ($ Million)

Figure No. 19 Diagnostic centers: Global Electro-Diagnostic Devices Market Value, 2021-2030 ($ Million)

Figure No. 20 Homecare: Global Electro-Diagnostic Devices Market Value, 2021-2030 ($ Million)

Figure No. 21 Global Electro-Diagnostic Devices Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure No. 22 North America Electro-Diagnostic Devices Market Value, 2021-2030 ($ Million)

Figure No. 23 North America Electro-Diagnostic Devices Market Share, By Product Type, 2022 & 2030 (%)

Figure No. 24 North America Electro-Diagnostic Devices Market Share, By Product Mobility, 2022 & 2030 (%)

Figure No. 25 North America Electro-Diagnostic Devices Market Share, By End User, 2022 & 2030 (%)

Figure No. 26 North America Electro-Diagnostic Devices Market Share, By Country, 2022 & 2030 (%)

Figure No. 27 South America Electro-Diagnostic Devices Market Value, 2021-2030 ($ Million)

Figure No. 28 South America Electro-Diagnostic Devices Market Share, By Product Type, 2022 & 2030 (%)

Figure No. 29 South America Electro-Diagnostic Devices Market Share, By Product Mobility, 2022 & 2030 (%)

Figure No. 30 South America Electro-Diagnostic Devices Market Share, By End User, 2022 & 2030 (%)

Figure No. 31 South America Electro-Diagnostic Devices Market Share, By Country, 2022 & 2030 (%)

Figure No. 32 Europe Electro-Diagnostic Devices Market Value, 2021-2030 ($ Million)

Figure No. 33 Europe Electro-Diagnostic Devices Market Share, By Product Type, 2022 & 2030 (%)

Figure No. 34 Europe Electro-Diagnostic Devices Market Share, By Product Mobility, 2022 & 2030 (%)

Figure No. 35 Europe Electro-Diagnostic Devices Market Share, By End User, 2022 & 2030 (%)

Figure No. 36 Europe Electro-Diagnostic Devices Market Share, By Country, 2022 & 2030 (%)

Figure No. 37 Asia-Pacific Electro-Diagnostic Devices Market Value, 2021-2030 ($ Million)

Figure No. 38 Asia-Pacific Electro-Diagnostic Devices Market Share, By Product Type, 2022 & 2030 (%)

Figure No. 39 Asia-Pacific Electro-Diagnostic Devices Market Share, By Product Mobility, 2022 & 2030 (%)

Figure No. 40 Asia-Pacific Electro-Diagnostic Devices Market Share, By End User, 2022 & 2030 (%)

Figure No. 41 Asia-Pacific Electro-Diagnostic Devices Market Share, By Country, 2022 & 2030 (%)

Figure No. 42 Middle East & Africa Electro-Diagnostic Devices Market Value, 2021-2030 ($ Million)

Figure No. 43 Middle East & Africa Electro-Diagnostic Devices Market Share, By Product Type, 2022 & 2030 (%)

Figure No. 44 Middle East & Africa Electro-Diagnostic Devices Market Share, By Product Mobility, 2022 & 2030 (%)

Figure No. 45 Middle East & Africa Electro-Diagnostic Devices Market Share, By End User, 2022 & 2030 (%)

Figure No. 46 Medtronic: Financials

Figure No. 47 Abbot: Financials

Figure No. 48 Boston Scientific: Financials

Figure No. 49 Bionet America, Inc.: Financials

Figure No. 50 Philips Healthcare: Financials

Figure No. 51 GE Healthcare: Financials

Figure No. 52 Cardinal Health: Financials

Figure No. 53 B. Braun Melsungen AG: Financials

Figure No. 54 Stryker Corporation: Financials

Figure No. 55 Becton, Dickinson and Company: Financials